Northeast Pharmaceutical Group Co. Ltd. A | Ownership
Companies that own Northeast Pharmaceutical Group Co. Ltd. A
China Huarong Asset Management Co., Ltd. (Invt Port)
34,338,415
7.25%
-5,690,160
2.23%
07/28/2018
Harfor Fund Management Co., Ltd.
5,115,985
1.08%
667,896
1.59%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
4,000,000
0.85%
4,000,000
0.46%
12/31/2017
China Resources SZITIC Trust Co., Ltd.
3,886,600
0.82%
-647,333
0.19%
03/31/2018
China Southern Asset Management Co., Ltd.
2,220,000
0.47%
1,170,068
0.04%
12/31/2017
The Vanguard Group, Inc.
759,012
0.16%
0
0%
07/31/2018
Tebon Fund Management Co. Ltd.
430,942
0.09%
430,942
0.31%
12/31/2017
HuaAn Fund Management Co., Ltd.
257,900
0.05%
257,900
0.01%
12/31/2017
GF Fund Management Co., Ltd.
201,600
0.04%
19,200
0.01%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
60,000
0.01%
-1,363,938
0%
12/31/2017
| Address |
Shenyang Economics & Tech Dev Zone
Shenyang Liaoning 110027
China
|
|
Employees
|
- |
| Website |
http://www.nepharm.com.cn |
| Updated |
07/08/2019 |
| Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sales of pharmaceutical products. It is doing business through three major segments-chemical synthetic API & bio-fermentation API, western medicinal preparation & micro-ecological preparation and medical business distribution. Its products include antibiotics, antiviral, anti-infective, antipyretic analgesic, vitamin & obstetrics series, nervous system, cardiovascular system, digestive system, biological diagnosis, respiratory drugs, food & feed additives and nutraceuticals, nutrition and decontamination products. |
